Stock Exchanging Hands at a Rapid Volume Today: SeaDrill Limited (NYSE:SDRL), Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE)

Following trading activity for SeaDrill Limited(NYSE:SDRL), we can see that the stock has moved onto today’s list of most actives. From the opening price, the stock has seen a change of -6.33% recently clocking in with a price of $0.34. Checking some other stock price data, we can see that the recent distance from the 50 day high was noted at -44.92% and the separation from the 50 day low is presently 1.20%. Looking out over the past year, company shares have been recorded -92.68% off the 52 week high and 1.20% away from the low over the same period.

Analyst Roundup

Covering sell-side analysts have recently weighed in on shares of SeaDrill Limited (NYSE:SDRL). At the time of writing, the First Call consensus price target for the company is $2.23. The current consensus recommendation provided by covering analysts is 3.60. This recommendation lands on a scale between 1 and 5. Analysts giving shares a rating of 1 or 2 would be indicating a Buy. A rating of 4 or 5 would represent a Sell recommendation. Analysts pegging the company with a rating of 3 would be indicating a Hold recommendation.

Prior Stock Performance Recap

Since the beginning of the calendar year, the stock is -89.54%. For the quarter, shares have been noted at -43.12%. Share performance for the month is currently at 5.66%. Tightening the gaze, stock performance for the last 5 trading days is -6.87%.

Recent session action on shares of Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) puts the stock on today’s active list. Since the open, shares have moved -3.52% after recently hitting the $6.27 mark.

Digging a bit further, company shares have been noted -75.83% off the 52 week high and -24.00% away from the 52 week low. Looking at a shorter time period, shares have been seen -69.75% away from the 50 day high and -50.07% off the 50 day low price.Covering sell-side analysts have recently weighed in on shares of Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE). At the time of writing, the First Call consensus price target for the company is $32.25. The current consensus recommendation provided by covering analysts is 1.60.

Since the beginning of the calendar year, the stock is -3.40%. For the quarter, shares have been noted at -21.73%. Share performance for the month is currently at -12.08%.

Tightening the gaze, stock performance for the last 5 trading days is -4.80%.

Leave a Comment